Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)

SHA:603811 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	172.68	173.04	294.14	213.51	83.32	72.31
Cash & Short-Term Investments	172.68	173.04	294.14	213.51	83.32	72.31
Cash Growth	-31.46%	-41.17%	37.77%	156.25%	15.23%	-48.75%
Accounts Receivable	49.66	72.91	93.18	90.44	78.79	78.68
Other Receivables	4.04	6.47	2.87	1.28	1.33	0.86
Receivables	53.7	79.38	96.05	91.72	80.12	79.54
Inventory	118.41	131.84	116.78	111.04	117	119.26
Other Current Assets	9.3	9.36	10.45	20.57	7.35	11.2
Total Current Assets	354.09	393.62	517.42	436.84	287.8	282.31
Property, Plant & Equipment	928.71	945.69	1,003	919.65	668.66	593
Long-Term Investments	324.36	314.87	281.13	234.01	208.2	204.72
Goodwill	-	-	-	-	2.42	5.33
Other Intangible Assets	63.34	63.95	66.66	68.45	70.19	69.95
Long-Term Deferred Tax Assets	4.94	6.3	5.94	17.47	5.16	4.91
Long-Term Deferred Charges	0.35	0.41	1.43	1.44	2.24	1.29
Other Long-Term Assets	4.39	3.55	17.55	41.24	77.83	45.39
Total Assets	1,680	1,728	1,893	1,719	1,322	1,207
Accounts Payable	51.96	84.67	118.91	54.79	57.5	61.11
Accrued Expenses	17.45	78.28	76.15	79.75	72.57	91.16
Short-Term Debt	50.1	51.1	117.33	76.5	86.36	40.87
Current Portion of Long-Term Debt	25.2	40.43	8.91	14.02	-	-
Current Portion of Leases	-	0.02	0.75	0.61	0.76	-
Current Income Taxes Payable	17.62	6.4	-	-	7.83	11.24
Current Unearned Revenue	9.17	12.22	4.38	13.74	6.11	4.81
Other Current Liabilities	54.8	18.38	16.22	18.59	15.75	18.18
Total Current Liabilities	226.28	291.5	342.65	257.99	246.87	227.38
Long-Term Debt	118.51	139.31	316.38	334.77	59.63	80.1
Long-Term Leases	-	-	0.47	0.91	1.79	-
Long-Term Unearned Revenue	17.99	18.77	21.29	16.93	12.22	11.7
Long-Term Deferred Tax Liabilities	13.33	13.74	15.37	17.56	3.11	1.62
Total Liabilities	376.11	463.31	696.15	628.16	323.62	320.79
Common Stock	327.3	327.3	327.3	233.79	233.79	166.99
Additional Paid-In Capital	143	143	143	236.51	238.08	304.88
Retained Earnings	902.84	857.04	721.8	617.36	514.22	401.87
Treasury Stock	-75.12	-67.26	-	-	-	-
Comprehensive Income & Other	-	-	0.21	0.23	0.22	0.21
Total Common Equity	1,298	1,260	1,192	1,088	986.31	873.95
Minority Interest	6.06	4.98	4.3	3.05	12.57	12.14
Shareholders' Equity	1,304	1,265	1,197	1,091	998.88	886.09
Total Liabilities & Equity	1,680	1,728	1,893	1,719	1,322	1,207
Total Debt	193.8	230.86	443.84	426.8	148.54	120.97
Net Cash (Debt)	-21.12	-57.82	-149.7	-213.3	-65.22	-48.66
Net Cash Per Share	-0.06	-0.18	-0.46	-0.65	-0.20	-0.15
Filing Date Shares Outstanding	327.3	318.89	327.3	327.3	327.3	327.3
Total Common Shares Outstanding	327.3	318.89	327.3	327.3	327.3	327.3
Working Capital	127.81	102.12	174.78	178.85	40.93	54.93
Book Value Per Share	3.97	3.95	3.64	3.32	3.01	2.67
Tangible Book Value	1,235	1,196	1,126	1,019	913.7	798.67
Tangible Book Value Per Share	3.77	3.75	3.44	3.11	2.79	2.44
Buildings	-	656.07	686.92	441.63	374.71	369.96
Machinery	-	672.02	687.58	600.01	443.66	396.15
Construction In Progress	-	5.15	6.16	182.6	99.91	27.26

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.